Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D.-L. Ou
Lenalidomide as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Exploration of Biomarkers for Treatment Efficacy
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Cost Effectiveness of Regorafenib as Second-Line Therapy for Patients With Advanced Hepatocellular Carcinoma
Cancer
Cancer Research
Oncology
Second-Line Treatment Options in Hepatocellular Carcinoma
Drugs in Context
Molecular Medicine
Pharmacology
Molecular Targeted Agents as Second-Line Treatment for Hepatocellular Carcinoma: A Meta-Analysis and Review
Oncotarget
Oncology
Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma
Modern Chemotherapy
Optimal First‐line Treatment for Advanced Thymic Carcinoma
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Economic Evaluation of Nivolumab as a Second-Line Treatment for Advanced Renal Cell Carcinoma From US and Chinese Perspectives
Cancer
Cancer Research
Oncology
Stereotactic Body Radiation Therapy as an Alternative Treatment for Small Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Phase II Study of Biweekly Plitidepsin as Second-Line Therapy for Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
Marine Drugs
Drug Discovery
Safety and Efficacy of 6-Thioguanine as a Second-Line Treatment for Autoimmune Hepatitis
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology